Wealth Enhancement Advisory Services LLC bought a new position in shares of Ouster, Inc. (NYSE:OUST - Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund bought 10,846 shares of the company's stock, valued at approximately $97,000.
A number of other institutional investors have also recently added to or reduced their stakes in OUST. Daiwa Securities Group Inc. boosted its stake in shares of Ouster by 18.0% in the 4th quarter. Daiwa Securities Group Inc. now owns 6,977 shares of the company's stock valued at $85,000 after purchasing an additional 1,063 shares during the last quarter. AlphaQuest LLC boosted its stake in Ouster by 916.0% during the fourth quarter. AlphaQuest LLC now owns 8,270 shares of the company's stock worth $101,000 after acquiring an additional 7,456 shares in the last quarter. ExodusPoint Capital Management LP bought a new position in Ouster during the fourth quarter worth $154,000. GAMMA Investing LLC boosted its stake in Ouster by 9,703.8% during the first quarter. GAMMA Investing LLC now owns 15,392 shares of the company's stock worth $138,000 after acquiring an additional 15,235 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its stake in Ouster by 35.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 18,645 shares of the company's stock worth $228,000 after acquiring an additional 4,839 shares in the last quarter. 31.45% of the stock is owned by institutional investors.
Analysts Set New Price Targets
OUST has been the topic of several research analyst reports. Cantor Fitzgerald reissued a "neutral" rating and set a $19.00 target price on shares of Ouster in a research note on Thursday, June 12th. Westpark Capital lowered shares of Ouster from a "buy" rating to a "hold" rating in a research note on Thursday, June 12th. Rosenblatt Securities reissued a "buy" rating and set a $17.00 target price on shares of Ouster in a research note on Friday, March 21st. UBS Group set a $16.00 price objective on shares of Ouster in a report on Thursday, March 27th. Finally, Oppenheimer assumed coverage on shares of Ouster in a report on Thursday, March 27th. They set an "outperform" rating and a $16.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Ouster presently has a consensus rating of "Moderate Buy" and an average target price of $15.24.
Read Our Latest Report on OUST
Ouster Price Performance
Shares of OUST stock traded down $1.12 on Friday, hitting $23.34. The stock had a trading volume of 2,448,698 shares, compared to its average volume of 1,647,188. The business has a 50 day moving average of $16.09 and a 200 day moving average of $11.74. The stock has a market cap of $1.25 billion, a price-to-earnings ratio of -9.08 and a beta of 2.75. Ouster, Inc. has a 12-month low of $5.84 and a 12-month high of $26.07.
Ouster Company Profile
(
Free Report)
Ouster, Inc provides lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries in Americas, the Asia-Pacific, Europe, the Middle East, and Africa. Its products include high-resolution scanning and solid-state digital lidar sensors, analog lidar sensors, and software solutions.
Further Reading

Before you consider Ouster, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ouster wasn't on the list.
While Ouster currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.